2021
DOI: 10.1186/s13018-021-02470-x
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: Background Studies evaluating the role of both corticosteroids and platelet-rich plasma (PRP) in the treatment of rotator cuff (RC) tendinopathies have been contradicting. We compared structural and clinical changes in RC muscles after corticosteroids and PRP injections. Methods This is a randomized double-blind clinical trial. All individuals with diagnosis of RC tendinitis during 2014–2017 were considered. Individuals were randoml… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(14 citation statements)
references
References 23 publications
(32 reference statements)
0
14
0
Order By: Relevance
“…The baseline VAS scores along with their change from base‐line can be found in Table 4 . At short‐ and intermediate‐term follow‐up, the change from baseline was comparable between the CS and PRP groups and no difference was observed (short‐term: MD = −0.30, 95% CI: −1.40, 0.08; p = 0.59; I 2 = 89% 12 , 26 , 28 , 32 , 34 ) (Intermediate‐term: MD = 0.28, 95% CI: −0.71, 1.28; p = 0.58; I 2 = 84% 26 , 27 , 28 , 31 , 32 ). At medium‐term follow‐up, no difference in the change of VAS score from base‐line was observed between the PRP and CS groups (MD = 0.39, 95% CI: −1.84, 2.62; p = 0.73; I 2 = 97% 12 , 28 , 32 , 34 ).…”
Section: Resultsmentioning
confidence: 92%
See 2 more Smart Citations
“…The baseline VAS scores along with their change from base‐line can be found in Table 4 . At short‐ and intermediate‐term follow‐up, the change from baseline was comparable between the CS and PRP groups and no difference was observed (short‐term: MD = −0.30, 95% CI: −1.40, 0.08; p = 0.59; I 2 = 89% 12 , 26 , 28 , 32 , 34 ) (Intermediate‐term: MD = 0.28, 95% CI: −0.71, 1.28; p = 0.58; I 2 = 84% 26 , 27 , 28 , 31 , 32 ). At medium‐term follow‐up, no difference in the change of VAS score from base‐line was observed between the PRP and CS groups (MD = 0.39, 95% CI: −1.84, 2.62; p = 0.73; I 2 = 97% 12 , 28 , 32 , 34 ).…”
Section: Resultsmentioning
confidence: 92%
“…DASH score was reported in four studies 25,26,28,30 (Figure 5). At the short-term follow-up, there exists a difference between the two cohorts such that the change from baseline was higher in the 0.67, 6.15; p = 0.01; I 2 = 0% 25,26,28,30 ).…”
Section: Dash Scorementioning
confidence: 99%
See 1 more Smart Citation
“…More than 50% of all shoulder pain cases are considered to be related to tendinopathies of the rotator cuff (RC), such as tendinosis and incomplete thickness tears of the supraspinatus [ 81 ]. In the management of RC tendinopathy, physical rehabilitation, rest, and nonsteroidal anti-inflammatory drugs are considered conventional treatments; however, the best treatment is still inconclusive [ 83 , 84 ].…”
Section: Rotator Cuff Tendinopathymentioning
confidence: 99%
“…A total of 641 patients were included (318 patients in the PRP group and 323 in the control group). The control groups in the included studies were as follows: 3 studies used placebo (saline or dry needle) (20)(21)(22); and 8 used conservative treatments (corticosteroids injection or physical therapy) (23)(24)(25)(26)(27)(28)(29)(30). Ten studies prepared PRP via centrifugation.…”
Section: Study Characteristicsmentioning
confidence: 99%